zearalenone, modified forms, metabolites, group tolerable daily intake, oestrogenicity, relative potency factors
This scientific opinion, published on 27 June 2016, replaces the earlier version published on 5 April 2016. Corrections were carried out to the data in Table 4 and Appendix C as well as an editorial correction on p.9. These changes do not affect the overall conclusions of the opinion. The original version is available on request as well as a version showing the changes made.
Panel members at the time of adoption:
Jan Alexander, Lars Barregard, Margherita Bignami, Sandra Ceccatelli, Bruce Cottrill, Michael Dinovi, Lutz Edler, Bettina Grasl-Kraupp, Christer Hogstrand, Laurentius (Ron) Hoogenboom, Helle Katrine Knutsen, Carlo Stefano Nebbia, Isabelle Oswald, Annette Petersen, Vera Maria Rogiers, Martin Rose, Alain-Claude Roudot, Tanja Schwerdtle, Christiane Vleminckx, Günter Vollmer and Heather Wallace
contam [at] efsa.europa.eu
EFSA Journal 2016;14(4):4425 [46 pp.].